Canada’s High Tide to acquire 80% of Colorado CBD firm NuLeaf Naturals

Canadian cannabis retail, CBD and accessory company High Tide announced a deal to acquire 80% of Denver-based CBD wellness product producer and distributor NuLeaf Naturals.

Aurora sends first shipment of ‘free’ marijuana to France

A subsidiary of Edmonton, Alberta-based Aurora Cannabis delivered its initial shipment of medical marijuana to France for use in the country’s pilot program, the company announced Wednesday.

No hallucination: Psychedelics could be next cannabis-like boom

Investors as well as cannabis companies and executives are rushing into psychedelics, a multibillion-dollar opportunity that reminds some of the early days of marijuana – although this infant industry could play out much differently.

Cannabis extractors are exploring THC remediation options

One is quick but expensive. The other is economical but slow – and tricky to get just right.

Extractors looking to isolate certain cannabinoids have long relied on chromatography to dial up or down the many cannabinoids in marijuana and hemp plants.

Curaleaf enters European cannabis market with $286 million acquisition of Emmac Life Sciences

Curaleaf Holdings said Tuesday it signed a $286 million definitive agreement to acquire London-based medical marijuana company Emmac Life Sciences, giving the Massachusetts-based multistate operator a major foothold in the European cannabis market and a leg up on rival businesses.

Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?

Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say.

Medical cannabinoid firm GW Pharma to be acquired by Jazz Pharmaceuticals for $7.2 billion

Global pharma company Jazz Pharmaceuticals has reached an agreement to buy U.K.-based GW Pharmaceuticals, one of the largest medical cannabinoid businesses in the world, for $7.2 billion in cash and stock, the drugmakers announced Wednesday.

France chooses companies to supply free medical cannabis for trial program

The French Agency for the Safety of Medicines and Health Products (ANSM) selected the companies that will supply France’s medical cannabis pilot program that’s intended to provide free products to patients enrolled in the trial.

Cannabis firm Canopy Growth sues GW Pharma, claiming patent infringement

Canadian cannabis producer Canopy Growth Corp. is suing Britain’s GW Pharmaceuticals in U.S. federal court, alleging that GW is knowingly infringing upon Canopy’s intellectual property.

European cannabis producer raises $20 million

Emmac Life Sciences, a European vertically integrated cannabis producer, said it raised 15 million pounds ($20 million) via an issue of convertible loan notes.

Colombian agency recommends allowing cannabis flower exports

The Colombian government might reconsider its ban on medical cannabis flower exports for commercial purposes.